“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our ...
In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was “taking these difficult but ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our ...
In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but ...
DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...